Selective NPY (Y5) antagonists

Details Selective NPY (Y5) antagonists Selective NPY (Y5) antagonists

2007-03-13

2007-03-13

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S197000, C544S198000, C544S208000, C544S209000

Reexamination Certificate

active

11099960

ABSTRACT:
This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.

REFERENCES:
patent: 3128272 (1964-04-01), Wear et al.
patent: 4383113 (1983-05-01), Levitt et al.
patent: 5166214 (1992-11-01), Billheimer et al.
patent: 5232921 (1993-08-01), Biziere et al.
patent: 5238936 (1993-08-01), Regnier et al.
patent: 5536722 (1996-07-01), Coe et al.
patent: 5550138 (1996-08-01), Sohda et al.
patent: 6124331 (2000-09-01), Marzabadi et al.
patent: 6214853 (2001-04-01), Marzabadi et al.
patent: 6218408 (2001-04-01), Marzabadi et al.
patent: 6222040 (2001-04-01), Marzabadi et al.
patent: 6225330 (2001-05-01), Marzabadi et al.
patent: 6340683 (2002-01-01), Marzabadi et al.
patent: 6569856 (2003-05-01), Marzabadi et al.
patent: 19824175 (1999-12-01), None
patent: 0 283 390 (1988-09-01), None
patent: 0 448 078 (1991-09-01), None
patent: 0 432 040 (1991-12-01), None
patent: 0 775 487 (1997-05-01), None
patent: 57151653 (1982-09-01), None
patent: WO 93/23381 (1993-11-01), None
patent: WO 94/18212 (1994-08-01), None
patent: WO 96/19457 (1996-06-01), None
patent: WO 97/19682 (1997-06-01), None
patent: WO 97/20823 (1997-06-01), None
patent: WO 98/35944 (1998-08-01), None
patent: WO 98/35957 (1998-08-01), None
patent: WO 99/001128 (1999-01-01), None
patent: WO 99/05138 (1999-02-01), None
patent: WO 99/32466 (1999-07-01), None
patent: WO 99/62892 (1999-12-01), None
patent: WO 00/68197 (2000-11-01), None
patent: WO 01/23389 (2001-04-01), None
patent: WO 01/44201 (2001-06-01), None
patent: WO 01/64675 (2001-09-01), None
Betancur, et al., TIPS vol. 18 (1997), 372-386.
Berlin, et al., Proc. Okla. Acad. Sci. 71 (1991): 29-33.
Brown, et al., Aust. J. Chem. 34 (1981): 2423-2429.
Khazi, et al., J. Hetereocyclic Chem., 4 (1995): 243-248.
McNally, et al., Bio. Med. Chem. Lett., 10 (2002): 212-216.
Ohkubo, et al., Chem. Pharm. Bull., 43(9) (1995): 1479-1504.
Peesapati, et al., OPPI Briefs, 25(5) (1993): 602-606.
Wettstein, et al., Pharmac. Ther. 65 (1995): 397-414.
Wieland, et al. Expert Opin. Investig. Drugs; 9(6)(2000): 1327-1346.
Xia, et al., Bioorg. Med. Chem. Lett. 6(7)(1996): 919-922.
Yamane, Kameji, Nippon Kagaku Zasshi 91(4)(1970): 395-399.
Yamane, et al., Nippon Kagaku Zasshi 90(6)(1969): 569-571.
Yamane, et al., Nippon Kagaku Zasshi 89(6)(1968): 612-614.

Affiliated with

Also associated with

Rating

Selective NPY (Y5) antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective NPY (Y5) antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective NPY (Y5) antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3757154